PB 11 of 2014
National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2014 (No. 2)
 
National Health Act 1953
___________________________________________________________________________
 
 
I, KIM BESSELL, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the
National Health Act 1953.
Dated   20 February 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KIM BESSELL
Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health
___________________________________________________________________________
 
 
1       Name of Instrument
 
(1)                This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2014 (No.2).
 
(2)                This Instrument may also be cited as PB 11 of 2014.
 
2              Commencement
This Instrument commences on 1 March 2014.
3              Amendments to PB 116 of 2010
Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010).
 
 
Schedule 1       Amendments
Section 3
[1]     Schedule 1, entry for Nevirapine in the form Tablet 200 mg
Insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:
                       
Nevipin
GN
EMP
C3586 C3587 C3588 C3589
 
120
5
D
[2]     Schedule 2, entry for UA with Responsible Person Actavis Pty Ltd and Australian Business Number 17 003 854 626
          Omit.
[3]     Schedule 2, after entry for GK with Responsible Person GlaxoSmithKline Australia Pty Ltd and Australian Business Number 47 100 162 481
Insert:
 
GN
Actavis Pty Ltd
17 003 854 626